• $99.0M
    Market Cap
  • -15.66%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
140,907
-0.09%
141,035
-3.21%
145,718
-29.94%
207,978
N/A
Operating Profit
-140,907
-0.09%
-141,035
-3.21%
-145,718
-29.94%
-207,978
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-5,303
+31.29%
-4,039
+52.88%
-2,642
+160.55%
-1,014
N/A
Interest Income and Expense and Net
-5,303
+31.29%
-4,039
+52.88%
-2,642
+160.55%
-1,014
N/A
Total Nonoperating Income and Expense
-5,303
+31.29%
-4,039
+52.88%
-2,642
+160.55%
-1,014
N/A
Income before Taxes
-140,907
-0.09%
-141,035
-3.21%
-145,718
-29.94%
-207,978
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-146,210
+0.78%
-145,074
-2.21%
-148,360
-29.01%
-208,992
N/A
Net Income from Continuing Operations Applicable to Common
-146,210
+0.78%
-145,074
-2.21%
-148,360
-29.01%
-208,992
N/A
Basic EPS and Net Income
-0.03
0.00%
-0.03
0.00%
-0.03
-25.00%
-0.04
N/A
Diluted EPS and Net Income
-0.03
0.00%
-0.03
0.00%
-0.03
-25.00%
-0.04
N/A
Basic Weighted Average Shares
5.2M
0.00%
5.2M
0.00%
5.2M
+10.01%
4.8M
N/A
Diluted Weighted Average Shares
5.2M
0.00%
5.2M
0.00%
5.2M
+10.01%
4.8M
N/A
Balance Sheet
Cash and Cash Equivalents
1,526
+703.16%
190
-15.56%
225
-65.91%
660
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1,526
+703.16%
190
-15.56%
225
-65.91%
660
N/A
Total Current Assets
1,526
+703.16%
190
-15.56%
225
-65.91%
660
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
1,526
+703.16%
190
-15.56%
225
-65.91%
660
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
76,077
+38.13%
55,077
+114.51%
25,676
N/A
Total Current Liabilities
593,593
+33.08%
446,047
+48.18%
301,008
+96.63%
153,083
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
593,593
+33.08%
446,047
+48.18%
301,008
+96.63%
153,083
N/A
Retained Earnings
-6.0M
+2.49%
-5.9M
+2.53%
-5.7M
+2.66%
-5.6M
N/A
Total Stockholders Equity
-592,067
+32.79%
-445,857
+48.23%
-300,783
+97.33%
-152,423
N/A
Total Shares Outstanding
5.2M
0.00%
5.2M
0.00%
5.2M
0.00%
5.2M
N/A
Cash Flow
Cash from Operating Activities
-20,906
-0.61%
-21,035
-29.50%
-29,836
+10.62%
-26,971
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
22,242
+5.91%
21,000
-28.57%
29,401
+14.51%
25,676
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-17,040.79%
-75.63%
-69,915.18%
+108.53%
-33,527.68%
+109.76%
-15,984.09%
N/A
Return on Equity
28.17%
-27.50%
38.86%
-40.64%
65.47%
-75.59%
268.19%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.003
+550.00%
0.0004
-42.86%
0.0007
-83.72%
0.004
N/A
Cash Ratio
0.003
+550.00%
0.0004
-42.86%
0.0007
-83.72%
0.004
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow